Ye Sihao, Zhang Wenjing, Shen Yao, Han Shuai, Hu Hai, Liang Yuexiang, Lin Zijian, Jin Yuepeng, Lawson Tom, Liu Yong, Cai Zhenzhai
Laboratory of Nanoscale Biosensing and Bioimaging (NBAB), School of Ophthalmology and Optometry, School of Biomedical Engineering, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China.
Department of Gastroenterology, the Second Affiliated Hospital of Wenzhou Medical University, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China.
Macromol Rapid Commun. 2023 Oct;44(20):e2300298. doi: 10.1002/marc.202300298. Epub 2023 Aug 21.
This work introduces a novel multifunctional system called UPIPF (upconversion-polydopamine-indocyanine-polyethylene-folic) for upconversion luminescent (UCL) imaging of cancer cells using near-infrared (NIR) illumination. The system demonstrates efficient inhibition of human hepatoma (HepG2) cancer cells through a combination of NIR-triggered photodynamic therapy (PDT) and enhanced photothermal therapy (PTT). Initially, upconversion nanoparticles (UCNP) are synthesized using a simple thermal decomposition method. To improve their biocompatibility and aqueous dispersibility, polydopamine (PDA) is introduced to the UCNP via a ligand exchange technique. Indocyanine green (ICG) molecules are electrostatically attached to the surface of the UCNP-polydopamine (UCNP@PDAs) complex to enhance the PDT and PTT effects. Moreover, polyethylene glycol (PEG)-modified folic acid (FA) is incorporated into the UCNP-polydopamine-indocyanine-green (UCNP@PDA-ICGs) nanoparticles to enhance their targeting capability against cancer cells. The excellent UCL properties of these UCNP enable the final UCNP@PDA-ICG-PEG-FA nanoparticles (referred to as UPIPF) to serve as a potential candidate for efficient anticancer drug delivery, real-time imaging, and early diagnosis of cancer cells. Furthermore, the UPIPF system exhibits PDT-assisted PTT effects, providing a convenient approach for efficient cancer cell inhibition (more than 99% of cells are killed). The prepared UPIPF system shows promise for early diagnosis and simultaneous treatment of malignant cancers.
这项工作介绍了一种名为UPIPF(上转换-聚多巴胺-吲哚菁绿-聚乙二醇-叶酸)的新型多功能系统,用于在近红外(NIR)光照下对癌细胞进行上转换发光(UCL)成像。该系统通过近红外触发的光动力疗法(PDT)和增强型光热疗法(PTT)相结合,有效抑制人肝癌(HepG2)癌细胞。首先,采用简单的热分解方法合成上转换纳米粒子(UCNP)。为了提高其生物相容性和水分散性,通过配体交换技术将聚多巴胺(PDA)引入UCNP。吲哚菁绿(ICG)分子通过静电作用附着在上转换纳米粒子-聚多巴胺(UCNP@PDAs)复合物表面,以增强PDT和PTT效果。此外,聚乙二醇(PEG)修饰的叶酸(FA)被掺入上转换纳米粒子-聚多巴胺-吲哚菁绿(UCNP@PDA-ICGs)纳米粒子中,以增强其对癌细胞的靶向能力。这些UCNP优异的UCL特性使最终的上转换纳米粒子-聚多巴胺-吲哚菁绿-聚乙二醇-叶酸纳米粒子(称为UPIPF)成为高效抗癌药物递送、癌细胞实时成像和早期诊断的潜在候选者。此外,UPIPF系统表现出PDT辅助的PTT效果,为有效抑制癌细胞(超过99%的细胞被杀死)提供了一种便捷方法。所制备的UPIPF系统在恶性肿瘤的早期诊断和同步治疗方面显示出前景。